Hypoglycemic agents and potential anti-inflammatory activity [PDF]
Journal of Inflammation Research, 2016 Vishal Kothari,1 John A Galdo,2 Suresh T Mathews3 1Department of Nutrition and Dietetics, Boshell Diabetes and Metabolic Diseases Research Program, Auburn University, Auburn, 2Department of Pharmacy Practice, 3Department of Nutrition and Dietetics ...
Kothari V, Galdo JA, Mathews ST
doaj +3 more sources
Design and synthesis of novel thiazolidine-2,4-diones as hypoglycemic agents
Journal of Saudi Chemical Society, 2016 Thiazolidinediones are well known for causing reduction in blood glucose levels. A number of thiazolidinediones have been approved for clinical use in diabetes.
Prasanna A. Datar, Sainath B. Aher
doaj +3 more sources
Risk of non-hypoglycemic agents for hypoglycemia-related hospitalization in patients with type 2 diabetes: a large-scale medical receipt database analysis [PDF]
BMJ Open Diabetes Research & Care, 2023 Introduction Hypoglycemia is listed as an adverse effect in the package inserts of not only hypoglycemic agents but also many other drugs. We aimed to clarify real-world factors related to an increased risk of hypoglycemia-related hospitalization (HRH ...
Takeshi Horii, Mai Otsuka, Takeo Yasu
doaj +2 more sources
Hypoglycemic Agents and Anesthetic Techniques to Ameliorate Stress Hyperglycemia in Critically Ill Patients: A Systematic Review [PDF]
Journal of Research in Pharmacy Practice, 2023 The concurrent utilization of hypoglycemic agents and anesthetic techniques has been demonstrated to mitigate stress hyperglycemia in critically ill patients without diabetes, thereby contributing to enhanced patient outcomes.
Fatemeh Rahimpour +4 more
doaj +2 more sources
Pharmacogenetics of hypoglycemic agents
Сахарный диабет, 2015 Despite the increase in the number of hypoglycemic agents, 35%–40% of patients with diabetes are unable to achieve adequate glycemic control. One of the reasons is the genetic heterogeneity of diabetes mellitus, requiring different treatment approaches ...
Irina Vladimirovna Kononenko +3 more
doaj +3 more sources
Mechanism of Action of the Hypoglycemic Agent Diphenyleneiodonium [PDF]
Journal of Biological Chemistry, 1973 Abstract The effects of the hypoglycemic agent diphenyleneiodonium have been studied both in vivo and in vitro. In 2-day-old rats, diphenyleneiodonium lowered whole body and blood glucose concentrations. At higher concentrations of the agent (10 µg per g), this was accompanied by increased glucose utilization and accumulation of lactic acid.
Henry A. Lardy +3 more
openaire +3 more sources
Hypoglycemic Coma in a Hemodialysis Patient Receiving Blood Glucose-Lowering Therapy With the Single Agent Teneligliptin [PDF]
Clinical Medicine Insights: Case Reports, 2018 Blood glucose management in patients undergoing dialysis is clinically challenging. In this population, most conventional oral hypoglycemic agents are contraindicated, especially from the perspective of pharmacokinetics. Dipeptidyl peptidase-4 inhibitors
Takumi Minezumi +5 more
doaj +2 more sources
Cocos Nucifera Endocarp Extract Exhibits Anti-diabetic and Antilipidemic Activities in Diabetic Rat Model [PDF]
International Journal of Scientific Research in Dental and Medical Sciences, 2022 Background and aim: The fruits of Cocos nucifera have long been used in traditional medicine as anti-inflammatory, antimicrobial, antiparasitic, anticancer, and cardiotonic.
Farjana Akter +5 more
doaj +1 more source
Adulteration of hypoglycemic products: the silent threat [PDF]
Romanian Journal of Medical Practice, 2023 Background. The growing tendency toward the adulteration of hypoglycemic products in the market to increase the seller’s profits, the increased promotions of such products by unscrupulous promoters, and the higher rate of consumption by diabetic patients
Raniah I. Alnaser +2 more
doaj +1 more source
Blood glucose, antidiabetic drugs, and risk of stroke [PDF]
Precision and Future Medicine, 2021 Diabetes mellitus is a well-established risk factor for stroke. Among people without baseline diabetes or cardiovascular disease, a low fasting glucose level of < 70 mg/dL is associated with an increased risk of stroke.
Meng Lee, Bruce Ovbiagele
doaj +1 more source